Abingdon Health PLC (ABDX)

Industry Diagnostics & Research

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

7.50p

Buy

8.50p

arrow-up0.00p (+0.00%)

Prices updated at 02 Apr 2026, 15:36 BST

Prices minimum 15 mins delay

Prices in GBX

FTSE All-Share

0.59%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Dr. Christopher William Hand

CEO

-

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

129

Head office

York Biotech Campus

York

United Kingdom

YO41 1LZ

+44 1904406050

info@abingdonhealth.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Thomas Edward Hayes Executive Director, Chief Financial Officer	-
Dr. Christopher William Hand Executive Director, Chairman	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Octopus Investments Limited	7,246,154
Unicorn Asset Management Ltd	1,927,750
Unicorn AIM VCT Series 3 ORD	1,927,750

Director dealings

Date chevron-l-regular chevron-r-regular	Action
14 Aug 2025	Sale

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.